SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Deals
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
December 15, 2022
 · 
4 min read
Drug Development
Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects
December 15, 2022
 · 
8 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 02, 2022
December 2, 2022
 · 
1 min read
Business
Astria Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 10, 2022
 · 
11 min read
Genetown
Astria Therapeutics to Present at Upcoming 2022 Jefferies London Healthcare Conference
November 9, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Present STAR-0215 Modeling and Simulation Data at the 2022 American College of Allergy, Asthma and Immunology Annual Meeting
November 7, 2022
 · 
5 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 02, 2022
November 2, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Host Virtual R&D Day: Update on STAR-0215 and Its Clinical Development
September 16, 2022
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Investment Conferences in September 2022
September 6, 2022
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 02, 2022
September 2, 2022
 · 
1 min read
Load More